share_log

賽生藥業：根據收購守則規則3.8刊發的公告

SCICLONE PHARMA: ANNOUNCEMENT PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE

香港交易所 ·  Apr 2 10:21
Summary by Moomoo AI
賽生藥業控股有限公司於2024年4月2日宣布，根據其首次公開發售後購股權計劃，已有42,000份購股權被行使，從而發行了相同數量的新股份。此次行使購股權後，公司的已發行股份總數達到627,688,692股。此外，公司還披露了購股權激勵計劃和首次公開發售後購股權計劃下剩餘的購股權數量，合共為70,189,812份。公司提醒股東及潛在投資者，關於私有化的建議、計劃及購股權要約的實行仍需滿足特定條件或獲得豁免。董事會對公告內容的準確性承擔責任，並確認經過合理查詢後，公告內容無遺漏且無誤導性陳述。
賽生藥業控股有限公司於2024年4月2日宣布，根據其首次公開發售後購股權計劃，已有42,000份購股權被行使，從而發行了相同數量的新股份。此次行使購股權後，公司的已發行股份總數達到627,688,692股。此外，公司還披露了購股權激勵計劃和首次公開發售後購股權計劃下剩餘的購股權數量，合共為70,189,812份。公司提醒股東及潛在投資者，關於私有化的建議、計劃及購股權要約的實行仍需滿足特定條件或獲得豁免。董事會對公告內容的準確性承擔責任，並確認經過合理查詢後，公告內容無遺漏且無誤導性陳述。
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON APRIL 2, 2024 THAT 42,000 SHARE OPTIONS HAVE BEEN EXERCISED UNDER ITS INITIAL PUBLIC OFFERING POST-IPO SHARE OPTION PLAN, RESULTING IN THE SAME NUMBER OF NEW SHARES BEING ISSUED. Following the exercise of the share option, the total number of issued shares of the Company reached 627,688,692 shares. In addition, the Company also disclosed the remaining number of warrants under the Share Option Incentive Program and the Initial Public Offering Possession Option Plan, totaling 70,189,812 shares. The Company reminds shareholders and potential investors that certain conditions or exemptions are still subject to the implementation of privatization proposals, plans and share purchase agreements. The Board is responsible for the accuracy of the contents of the announcement and verifies, after reasonable enquiry, that the contents of the announcement are free of omissions and are free from misleading statements.
SESONG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED ON APRIL 2, 2024 THAT 42,000 SHARE OPTIONS HAVE BEEN EXERCISED UNDER ITS INITIAL PUBLIC OFFERING POST-IPO SHARE OPTION PLAN, RESULTING IN THE SAME NUMBER OF NEW SHARES BEING ISSUED. Following the exercise of the share option, the total number of issued shares of the Company reached 627,688,692 shares. In addition, the Company also disclosed the remaining number of warrants under the Share Option Incentive Program and the Initial Public Offering Possession Option Plan, totaling 70,189,812 shares. The Company reminds shareholders and potential investors that certain conditions or exemptions are still subject to the implementation of privatization proposals, plans and share purchase agreements. The Board is responsible for the accuracy of the contents of the announcement and verifies, after reasonable enquiry, that the contents of the announcement are free of omissions and are free from misleading statements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more